Boxplot of four RNA expression levels (in log₁₀ scale) according to treatment response.

<p>The expression levels of interesting transcripts were normalized to the housekeeping PPIA (peptidylprolyl isomerase A) and TBP (TATA-box binding protein) gene transcripts. Since there was no difference between control genes, results were presented as copies of target gene per copy of PPIA. The median values and their corresponding logarithmic values in brackets were respectively: for VEGF₁₂₁ PR 1222 (7.1), SD 425 (6.0) and Failure 241 (5.4); and for VEGF₁₆₅ PR 905 (6.8), SD 460 (6.1) and Failure 352 (5.8). (*) for p<0.05.</p

Additional file 1: of Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer

Table S1. Oligonucleotides for QM-MSP. (DOC 37 kb

Kaplan-Meier survival curve according to the ratio VEGF₁₂₁/VEGF_165.

<p>Kaplan-Meier survival curve according to the ratio VEGF₁₂₁/VEGF_165.</p

Patient Characteristics.

<p>MSKCC: Memorial Sloan-Kettering Cancer Center; ECOG: Eastern Cooperative Oncology Group.</p><p>*Several sites per patient.</p